登录注册

mRNA-based influenza vaccine expands the B cell response breadth in humans

Nature Immunology

https://doi.org/10.1038/s41590-026-02569-5

Related products

Catalog No.	Product Name	Description	Target
VK515016	Anti-Influenza A virus HA/Hemagglutinin Reference Antibody (Diridavumab	Diridavumab (VK515016) is a research-grade recombinant antibody targeting HA/Hemagglutinin. Produced in mammalian cells with native-like glycosylation. Highlights ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns.	HA/Hemagglutinin